{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:44:43Z","timestamp":1788813883128,"version":"build-2803163510"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ejso.2020.07.043","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T04:51:02Z","timestamp":1608267062000},"page":"199-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG)"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3190-6572","authenticated-orcid":false,"given":"Philip","family":"Turton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2752-5814","authenticated-orcid":false,"given":"Dima","family":"El-Sharkawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Lyburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5922-9630","authenticated-orcid":false,"given":"Bhupinder","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preethika","family":"Mahalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8439-4507","authenticated-orcid":false,"given":"Suzanne D.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"MacNeill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7259-5088","authenticated-orcid":false,"given":"Nigel","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejso.2020.07.043_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006534-197046010-00001","article-title":"Our experiences with the silastic gel breast prosthesis","volume":"46","author":"Cronin","year":"1970","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejso.2020.07.043_bib5","author":"Food and Drug Administration"},{"issue":"3","key":"10.1016\/j.ejso.2020.07.043_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamaoncol.2017.4510","article-title":"Breast implants and the risk of anaplastic large-cell lymphoma in the breast","volume":"4","author":"de Boer","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejso.2020.07.043_bib7","author":"Food and Drug Administration"},{"key":"10.1016\/j.ejso.2020.07.043_bib8","series-title":"Silicone gel breast implants: the report of the independent review group","author":"Independent Review Group","year":"1998"},{"key":"10.1016\/j.ejso.2020.07.043_bib9","article-title":"Safety of silicone breast implants","author":"Bondurant","year":"1999"},{"issue":"2","key":"10.1016\/j.ejso.2020.07.043_bib10","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00006534-199708000-00065","article-title":"Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant","volume":"100","author":"Keech","year":"1997","journal-title":"Plast Reconstr Surg"},{"issue":"7","key":"10.1016\/j.ejso.2020.07.043_bib11","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.bjps.2007.03.027","article-title":"Primary breast lymphoma in a patient with silicone breast implants: a case report and review of the literature","volume":"61","author":"Newman","year":"2008","journal-title":"J\u00a0Plast Reconstr Aesthetic Surg"},{"issue":"6","key":"10.1016\/j.ejso.2020.07.043_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw294","article-title":"Primary breast lymphoma in the United States: 1975-2013","volume":"109","author":"Thomas","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2020.07.043_bib13","series-title":"SEER cancer statistics review","author":"Howlader","year":"2019"},{"issue":"11","key":"10.1016\/j.ejso.2020.07.043_bib14","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/jnci\/85.11.892","article-title":"The lifetime risk of developing breast cancer","volume":"85","author":"Feuer","year":"1993","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2020.07.043_bib16","author":"Medicines and Healthcare products Regulatory Agency"},{"issue":"3","key":"10.1016\/j.ejso.2020.07.043_bib2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/PRS.0000000000001033","article-title":"Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases","volume":"135","author":"Brody","year":"2015","journal-title":"Plast Reconstr Surg"},{"issue":"20","key":"10.1016\/j.ejso.2020.07.043_bib17","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ejso.2020.07.043_bib18","author":"Food and Drug Administration"},{"issue":"8","key":"10.1016\/j.ejso.2020.07.043_bib3","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.ejso.2017.05.004","article-title":"Breast implant associated anaplastic large cell lymphoma: the UK experience. Recommendations on its management and implications for informed consent","volume":"43","author":"Johnson","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.07.043_bib19","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/PRS.0000000000003282","article-title":"U.S. Epidemiology of breast implant-associated anaplastic large cell lymphoma","volume":"139","author":"Doren","year":"2017","journal-title":"Plast Reconstr Surg"},{"issue":"12","key":"10.1016\/j.ejso.2020.07.043_bib20","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jamasurg.2017.4026","article-title":"Breast implant-associated anaplastic large cell lymphoma: a systematic review","volume":"152","author":"Leberfinger","year":"2017","journal-title":"JAMA Surg"},{"issue":"4","key":"10.1016\/j.ejso.2020.07.043_bib21","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/PRS.0000000000003654","article-title":"Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk","volume":"140","author":"Loch-Wilkinson","year":"2017","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.ejso.2020.07.043_bib22","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/PRS.0000000000003233","article-title":"Global adverse event reports of breast implant-associated ALCL: an international review of 40 government authority databases","volume":"139","author":"Srinivasa","year":"2017","journal-title":"Plast Reconstr Surg"},{"issue":"15_suppl","key":"10.1016\/j.ejso.2020.07.043_bib23","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1200\/JCO.2019.37.15_suppl.1565","article-title":"Risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3,546 women prospectively followed after receiving textured breast implants","volume":"37","author":"Ghione","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.07.043_bib24","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bjps.2019.11.064","article-title":"Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants","volume":"73","author":"Cordeiro","year":"2020","journal-title":"J\u00a0Plast Reconstr Aesthetic Surg"},{"key":"10.1016\/j.ejso.2020.07.043_bib25","article-title":"Breast implant-associated anaplastic large cell lymphoma in Australia: a longitudinal study of implant and other related risk factors","author":"Loch-Wilkinson","year":"2019","journal-title":"Aesthetic Surg J"},{"issue":"5","key":"10.1016\/j.ejso.2020.07.043_bib26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.bjps.2020.02.040","article-title":"Editorial on the article \"Risk of breast implant associated anaplastic large cell lymphoma in a cohort of 3546 women prospectively followed long term after reconstruction with macro-textured breast implants","volume":"73","author":"Mercer","year":"2020","journal-title":"J\u00a0Plast Reconstr Aesthetic Surg"},{"key":"10.1016\/j.ejso.2020.07.043_bib27","author":"National Comprehensive Cancer Network"},{"issue":"3","key":"10.1016\/j.ejso.2020.07.043_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/asj\/sjw259","article-title":"NCCN consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma","volume":"37","author":"Clemens","year":"2017","journal-title":"Aesthetic Surg J"},{"issue":"Supplement_1","key":"10.1016\/j.ejso.2020.07.043_bib29","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/asj\/sjy331","article-title":"NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)","volume":"39","author":"Clemens","year":"2019","journal-title":"Aesthetic Surg J"},{"issue":"6","key":"10.1016\/j.ejso.2020.07.043_bib30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/his.13932","article-title":"Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management","volume":"75","author":"Jones","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.ejso.2020.07.043_bib31","author":"Clinical Audit"},{"issue":"11","key":"10.1016\/j.ejso.2020.07.043_bib32","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.bjps.2018.07.004","article-title":"Breast imaging for aesthetic surgery: British Society of Breast Radiology (BSBR), Association of Breast Surgery Great Britain & Ireland (ABS), British Association of Plastic Reconstructive and Aesthetic Surgeons (BAPRAS).","volume":"71","author":"Lowes","year":"2018","journal-title":"J\u00a0Plast Reconstr Aesthetic Surg"},{"issue":"2","key":"10.1016\/j.ejso.2020.07.043_bib33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2013.52.7911","article-title":"Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients","volume":"32","author":"Miranda","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.07.043_bib34","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1097\/PRS.0000000000005571","article-title":"Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): initial report of findings","author":"McCarthy","year":"2019","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.ejso.2020.07.043_bib35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.2015.63.3412","article-title":"Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma","volume":"34","author":"Clemens","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.07.043_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-014-3034-3","article-title":"Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients","volume":"147","author":"Adrada","year":"2014","journal-title":"Breast Canc Res Treat"},{"issue":"1","key":"10.1016\/j.ejso.2020.07.043_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PRS.0000000000002837","article-title":"Risk factor Analysis for capsular contracture, malposition, and late seroma in subjects receiving Natrelle 410 form-stable silicone breast implants","volume":"139","author":"McGuire","year":"2017","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.ejso.2020.07.043_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00266-010-9607-6","article-title":"Seroma as a late complication after breast augmentation","volume":"35","author":"Pinchuk","year":"2011","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.ejso.2020.07.043_bib39","author":"National Institute for Health and Care Excellence"},{"key":"10.1016\/j.ejso.2020.07.043_bib40","first-page":"5647940","article-title":"Increasing evidence for the association of breast implant-associated anaplastic large cell lymphoma and Li Fraumeni Syndrome","volume":"2019","author":"Adlard","year":"2019","journal-title":"Case Rep Genet"},{"key":"10.1016\/j.ejso.2020.07.043_bib41","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2019004498","article-title":"Increased prevalence of BRCA1\/2 mutations in women with macro-textured breast implants and anaplastic large cell lymphoma of the breast","author":"De Boer","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ejso.2020.07.043_bib42","unstructured":"National Genomic Test Directory Testing Criteria for Rare and Inherited Disease: NHS England; [Available from:: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2018\/08\/rare-and-inherited-disease-eligibility-criteria-march-19.pdf."},{"issue":"1","key":"10.1016\/j.ejso.2020.07.043_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PRS.0b013e318217fdb0","article-title":"Managing late periprosthetic fluid collections (seroma) in patients with breast implants: a consensus panel recommendation and review of the literature","volume":"128","author":"Bengtson","year":"2011","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.ejso.2020.07.043_bib44","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1148\/rg.2017160086","article-title":"Multimodality imaging-based evaluation of single-lumen silicone breast implants for rupture","volume":"37","author":"Seiler","year":"2017","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.ejso.2020.07.043_bib45","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1148\/rg.2020190198","article-title":"Breast implant-associated anaplastic large cell lymphoma: review and multiparametric imaging paradigms","volume":"40","author":"Sharma","year":"2020","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.ejso.2020.07.043_bib46","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/tbj.13312","article-title":"Breast implant-associated Anaplastic large cell lymphoma (BIA-ALCL): imaging findings","volume":"25","author":"Montes Fernandez","year":"2019","journal-title":"Breast J"},{"issue":"27","key":"10.1016\/j.ejso.2020.07.043_bib47","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the international conference on malignant lymphomas imaging working group","volume":"32","author":"Barrington","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2020.07.043_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181097","article-title":"Cytological diagnostic features of late breast implant seromas: from reactive to anaplastic large cell lymphoma","volume":"12","author":"Di Napoli","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.ejso.2020.07.043_bib49","author":"National Institute for Health and Care Excellence"},{"key":"10.1016\/j.ejso.2020.07.043_bib50","article-title":"Breast implant-associated EBV-positive large B-cell lymphomas: report of three cases","author":"Rodriguez-Pinilla","year":"2019","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.ejso.2020.07.043_bib51","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0002-9440(10)65018-3","article-title":"Regulation of CD30 antigen expression and its potential significance for human disease","volume":"156","author":"Kadin","year":"2000","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1016\/j.ejso.2020.07.043_bib52","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1200\/JCO.19.02778","article-title":"Best practices guideline for the pathologic diagnosis of breast implant-associated anaplastic large-cell lymphoma","volume":"38","author":"Jaffe","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.07.043_bib53","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/annonc\/mdv575","article-title":"Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes","volume":"27","author":"Laurent","year":"2016","journal-title":"Ann Oncol"},{"issue":"90","key":"10.1016\/j.ejso.2020.07.043_bib54","doi-asserted-by":"crossref","first-page":"36126","DOI":"10.18632\/oncotarget.26308","article-title":"Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma","volume":"9","author":"Blombery","year":"2018","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.ejso.2020.07.043_bib55","first-page":"360","article-title":"Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL","volume":"135","author":"Laurent","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ejso.2020.07.043_bib56","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2017-12-821868","article-title":"Genetic subtyping of breast implant-associated anaplastic large cell lymphoma","volume":"132","author":"Oishi","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ejso.2020.07.043_bib57","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00428-018-2352-y","article-title":"Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma","volume":"473","author":"Letourneau","year":"2018","journal-title":"Virchows Arch"},{"issue":"5","key":"10.1016\/j.ejso.2020.07.043_bib58","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/bjh.14431","article-title":"Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK\/STAT signalling pathway genes, TP53 and DNMT3A","volume":"180","author":"Di Napoli","year":"2018","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.ejso.2020.07.043_bib59","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ajpath.2019.09.005","article-title":"Cell of origin and immunologic events in the pathogenesis of breast implant-associated anaplastic large-cell lymphoma","volume":"190","author":"Turner","year":"2020","journal-title":"Am J Pathol"},{"issue":"Suppl_1","key":"10.1016\/j.ejso.2020.07.043_bib60","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1093\/asj\/sjy229","article-title":"The cellular origins of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): implications for immunogenesis","volume":"39","author":"Turner","year":"2019","journal-title":"Aesthetic Surg J"},{"issue":"9","key":"10.1016\/j.ejso.2020.07.043_bib61","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.3324\/haematol.2016.146118","article-title":"Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma","volume":"101","author":"Blombery","year":"2016","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.ejso.2020.07.043_bib62","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13000-018-0688-x","article-title":"Breast implant-associated anaplastic large cell lymphoma in a Li-FRAUMENI patient: a case report","volume":"13","author":"Pastorello","year":"2018","journal-title":"Diagn Pathol"},{"issue":"9","key":"10.1016\/j.ejso.2020.07.043_bib63","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.160232","article-title":"Challenging perspectives on the cellular origins of lymphoma","volume":"6","author":"Malcolm","year":"2016","journal-title":"Open Biol"},{"key":"10.1016\/j.ejso.2020.07.043_bib64","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.humpath.2018.04.007","article-title":"IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis","volume":"78","author":"Kadin","year":"2018","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.ejso.2020.07.043_bib65","doi-asserted-by":"crossref","first-page":"NP240","DOI":"10.1093\/asj\/sjz049","article-title":"Commentary on: a case report of a breast implant-associated plasmacytoma and literature review of non-ALCL breast implant-associated neoplasms","volume":"39","author":"Kadin","year":"2019","journal-title":"Aesthetic Surg J"},{"issue":"2","key":"10.1016\/j.ejso.2020.07.043_bib66","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00266-012-0025-9","article-title":"Silicone lymphadenopathy after breast augmentation: case reports, review of the literature, and current thoughts","volume":"37","author":"Zambacos","year":"2013","journal-title":"Aesthetic Plast Surg"},{"issue":"6","key":"10.1016\/j.ejso.2020.07.043_bib67","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4174\/astr.2017.93.6.331","article-title":"Extensive silicone lymphadenopathy after breast implant insertion mimicking malignant lymphadenopathy","volume":"93","author":"Lee","year":"2017","journal-title":"Ann Surg Treat Res"},{"issue":"4","key":"10.1016\/j.ejso.2020.07.043_bib68","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/01.pas.0000155145.60670.e4","article-title":"Pathology of lymph nodes from patients with breast implants: a histologic and spectroscopic evaluation","volume":"29","author":"Katzin","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2020.07.043_bib69","doi-asserted-by":"crossref","DOI":"10.1097\/PRS.0000000000005569","article-title":"Breast reconstruction following breast implant-associated anaplastic large cell lymphoma","author":"Lamaris","year":"2019","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.ejso.2020.07.043_bib70","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000355861","article-title":"Breast implant-associated anaplastic large-cell lymphoma can be a diagnostic challenge for pathologists","volume":"58","author":"Talagas","year":"2014","journal-title":"Acta Cytol"},{"key":"10.1016\/j.ejso.2020.07.043_bib71","article-title":"A\u00a0proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma","author":"Lyapichev","year":"2019","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.ejso.2020.07.043_bib72","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.2011.08651.x","article-title":"Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma)","volume":"153","author":"Dearden","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejso.2020.07.043_bib73","first-page":"623924","article-title":"A\u00a0systematic review and meta-analysis of front-line anthracycline-based chemotherapy regimens for peripheral T-cell lymphoma","volume":"2011","author":"Abouyabis","year":"2011","journal-title":"Isrn Hematology Print"},{"issue":"18","key":"10.1016\/j.ejso.2020.07.043_bib74","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1182\/blood-2010-02-270785","article-title":"Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group","volume":"116","author":"Schmitz","year":"2010","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.ejso.2020.07.043_bib75","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","article-title":"Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01","volume":"30","author":"d\u2019Amore","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"Suppl 5","key":"10.1016\/j.ejso.2020.07.043_bib76","doi-asserted-by":"crossref","first-page":"v108","DOI":"10.1093\/annonc\/mdv201","article-title":"Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"d\u2019Amore","year":"2015","journal-title":"Ann Oncol"},{"issue":"24","key":"10.1016\/j.ejso.2020.07.043_bib77","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1182\/bloodadvances.2017010819","article-title":"Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphoma","volume":"1","author":"Kim","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.ejso.2020.07.043_bib78","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.2147\/OTT.S189825","article-title":"Comparison of CHOP vs CHOPE for treatment of peripheral T-cell lymphoma: a meta-analysis","volume":"12","author":"Deng","year":"2019","journal-title":"OncoTargets Ther"},{"issue":"10168","key":"10.1016\/j.ejso.2020.07.043_bib79","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.ejso.2020.07.043_bib80","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1200\/JCO.2011.38.0402","article-title":"Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study","volume":"30","author":"Pro","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.07.043_bib81","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1756-8722-7-24","article-title":"Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies","volume":"7","author":"Bartlett","year":"2014","journal-title":"J\u00a0Hematol Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.07.043_bib82","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/ccr3.2142","article-title":"Brentuximab vedotin as monotherapy for unresectable breast implant-associated anaplastic large cell lymphoma","volume":"7","author":"Stack","year":"2019","journal-title":"Clin Case Rep"},{"issue":"4","key":"10.1016\/j.ejso.2020.07.043_bib83","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/ccr3.1382","article-title":"Frontline brentuximab vedotin in breast implant-associated anaplastic large-cell lymphoma","volume":"6","author":"Alderuccio","year":"2018","journal-title":"Clin Case Rep"},{"issue":"5","key":"10.1016\/j.ejso.2020.07.043_bib84","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.bbmt.2015.12.004","article-title":"Efficacy of high-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphomas as front-line consolidation or in the relapsed\/refractory setting: a systematic review\/meta-analysis","volume":"22","author":"El-Asmar","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.ejso.2020.07.043_bib85","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/annonc\/mdx787","article-title":"Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers","volume":"29","author":"Fossard","year":"2018","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2020.07.043_bib86","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/cncr.31861","article-title":"The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: report from COMPLETE, a prospective, multicenter cohort study","volume":"125","author":"Park","year":"2019","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2020.07.043_bib87","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.clml.2015.12.006","article-title":"Role of surveillance imaging in patients with peripheral T-cell lymphoma","volume":"16","author":"Tang","year":"2016","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"issue":"12","key":"10.1016\/j.ejso.2020.07.043_bib88","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1080\/10428194.2017.1300888","article-title":"Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study","volume":"58","author":"Cederleuf","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"21","key":"10.1016\/j.ejso.2020.07.043_bib89","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1200\/JCO.2012.42.6189","article-title":"Who benefits from surveillance imaging?","volume":"30","author":"Armitage","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.07.043_bib90","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/bjh.12687","article-title":"Hodgkin lymphoma patients in first remission: routine positron emission tomography\/computerized tomography imaging is not superior to clinical follow-up for patients with no residual mass","volume":"164","author":"Dann","year":"2014","journal-title":"Br J Haematol"},{"issue":"31","key":"10.1016\/j.ejso.2020.07.043_bib91","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1200\/JCO.2014.55.7561","article-title":"Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma","volume":"32","author":"Thompson","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.07.043_bib92","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/asheducation-2013.1.9","article-title":"The ASH Choosing Wisely(R)campaign: five hematologic tests and treatments to question","volume":"2013","author":"Hicks","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320306880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320306880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:36:41Z","timestamp":1760060201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320306880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0748798320306880"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.07.043","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.07.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of Elsevier Ltd, British Association of Surgical Oncology & European Society of Surgical Oncology; published by Wiley on behalf of John Wiley and Sons Limited; and published by Elsevier Ltd on behalf of British Association of Plastic, Reconstructive and Aesthetic Surgeons. All rights reserved.","name":"copyright","label":"Copyright"}]}}